The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 322.50
Ask: 323.50
Change: -4.50 (-1.38%)
Spread: 1.00 (0.31%)
Open: 326.50
High: 326.50
Low: 322.00
Prev. Close: 326.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

9 Nov 2023 07:00

RNS Number : 8547S
Morgan Advanced Materials PLC
09 November 2023
 

 

 

Press Release

Morgan Advanced Materials plc

9 November 2023

 

Trading Update

Strong financial position, growth outlook unchanged

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for technically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2023.

Current Trading

Sales for the nine months to September 2023 were 2.4% higher for the Group, on an organic constant-currency basis, compared with the same period last year. Our recovery from the cyber incident we experienced at the start of the year has progressed as planned. By business unit, organic constant-currency sales performance for the nine months to September 2023, compared with the same period last year, were as follows:

 

Thermal Ceramics

+0.9%

Molten Metal Systems

-7.2%

Electrical Carbon

+6.5%

Seals and Bearings

-5.4%

Technical Ceramics

+7.7%

 

Outlook

Our outlook for full year organic revenue growth is unchanged at 2-4%. The group has continued to benefit from strong growth in its Semiconductor, Healthcare and Aerospace end-markets, offsetting weakness in European and China industrial markets. Seals & Bearings performance was influenced in part by phasing of armour orders.

Margins have continued to improve sequentially, despite an adverse movement in FX impacting the second half by circa £3m.

We continue to pursue opportunities to remove cost to ensure we enter 2024 with the right cost structure. Although uncertainty remains around some of our end markets, looking forward we expect continued margin improvement and good growth in H1 2024, especially given the cyber incident in the comparative period. In particular, we expect sustained growth in Semiconductor driven by demand for Silicon Carbide applications in power electronics.

 

Pete Raby, Chief Executive Officer, said:

"Our business is growing as anticipated, benefitting from our leading, differentiated positions in selected markets and despite the challenging environment, with inflation continuing to be more than offset by pricing.

Our Board remains committed to our financial framework. Investment in capacity for our faster growing segments is accelerating, and we continue to investigate inorganic investments as well as consider opportunities for enhanced returns to shareholders."

The full year results are expected to be released on 14 March 2024. A Capital Markets Event will be held during Q2 2024, with updates on progress in our faster growing markets, opportunities for efficiency improvement and investment plans.

 

For further enquiries:

Pete Raby

Morgan Advanced Materials plc

01753 837000

Richard Armitage

Nina Coad

Brunswick

0207 404 5959

 

1. Company-compiled summary of current analysts' forecasts for adjusted operating profit for 2023 is a range of £120.5 million to £125.0 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFPEEDDFFA
Date   Source Headline
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding
23rd Mar 202211:01 amRNSDirector/PDMR Shareholding
22nd Mar 20225:04 pmRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSFull-year results
10th Jan 202211:30 amRNSHolding(s) in Company
15th Dec 202110:00 amRNSBlock listing Interim Review
7th Dec 202112:30 pmRNSHolding in Company
26th Nov 20213:32 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSTrading Update
18th Oct 202112:21 pmRNSDirector/PDMR Shareholding
18th Oct 202112:20 pmRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSCFO Appointment
14th Oct 20219:15 amRNSHolding in Company
11th Oct 202110:45 amRNSHolding in Company
28th Sep 20213:15 pmRNSDirector/PDMR Shareholding
17th Sep 20213:58 pmRNSDirector/PDMR Shareholding
16th Sep 202111:30 amRNSDirector/PDMR Shareholding
5th Aug 20211:39 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
15th Jun 20219:38 amRNSBlock Listing Interim Review
10th Jun 20219:18 amRNSDirector/PDMR Shareholding
27th May 20214:02 pmRNSDirector/PDMR Shareholding
25th May 20213:38 pmRNSDirector/PDMR Shareholding
11th May 202110:20 amRNSDirector/PDMR Shareholding
6th May 202111:54 amRNSResult of AGM
6th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTrading Update
31st Mar 20212:08 pmRNSAnnual Financial Report
26th Mar 20219:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.